vs
先锋自然资源公司（PR）与登士柏西诺德（XRAY）财务数据对比。点击上方公司名可切换其他公司
先锋自然资源公司的季度营收约是登士柏西诺德的1.2倍（$1.2B vs $961.0M），先锋自然资源公司净利率更高（29.0% vs -15.2%，领先44.2%），登士柏西诺德同比增速更快（6.2% vs -9.8%），过去两年登士柏西诺德的营收复合增速更高（0.4% vs -3.0%）
先锋自然资源公司总部位于美国得克萨斯州欧文市，主要从事油气勘探业务，运营覆盖二叠纪盆地Spraberry产区的克莱恩页岩区块，是该区域最大的土地权益持有方，2024年5月被埃克森美孚收购。
登士柏西诺德是美国牙科设备及耗材制造商，业务覆盖全球120多个国家，在21个国家设有生产工厂。该公司前身为1993年Gendex公司以5.9亿美元收购登士柏国际后整合组建的企业，是全球牙科领域的重要供应商。
PR vs XRAY — 直观对比
营收规模更大
PR
是对方的1.2倍
$961.0M
营收增速更快
XRAY
高出16.0%
-9.8%
净利率更高
PR
高出44.2%
-15.2%
两年增速更快
XRAY
近两年复合增速
-3.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $961.0M |
| 净利润 | $339.5M | $-146.0M |
| 毛利率 | — | 46.1% |
| 营业利润率 | 23.1% | -14.5% |
| 净利率 | 29.0% | -15.2% |
| 营收同比 | -9.8% | 6.2% |
| 净利润同比 | 56.7% | 66.0% |
| 每股收益（稀释后） | $0.48 | $-0.74 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRXRAY
| Q4 25 | $1.2B | $961.0M | ||
| Q3 25 | $1.3B | $904.0M | ||
| Q2 25 | $1.2B | $936.0M | ||
| Q1 25 | $1.4B | $879.0M | ||
| Q4 24 | $1.3B | $905.0M | ||
| Q3 24 | $1.2B | $951.0M | ||
| Q2 24 | $1.2B | $984.0M | ||
| Q1 24 | $1.2B | $953.0M |
净利润PRXRAY
| Q4 25 | $339.5M | $-146.0M | ||
| Q3 25 | $59.2M | $-427.0M | ||
| Q2 25 | $207.1M | $-45.0M | ||
| Q1 25 | $329.3M | $20.0M | ||
| Q4 24 | $216.7M | $-430.0M | ||
| Q3 24 | $386.4M | $-494.0M | ||
| Q2 24 | $235.1M | $-4.0M | ||
| Q1 24 | $146.6M | $18.0M |
毛利率PRXRAY
| Q4 25 | — | 46.1% | ||
| Q3 25 | — | 48.8% | ||
| Q2 25 | — | 52.4% | ||
| Q1 25 | — | 53.0% | ||
| Q4 24 | — | 49.3% | ||
| Q3 24 | — | 52.1% | ||
| Q2 24 | — | 51.9% | ||
| Q1 24 | — | 53.1% |
营业利润率PRXRAY
| Q4 25 | 23.1% | -14.5% | ||
| Q3 25 | 29.6% | -24.1% | ||
| Q2 25 | 24.8% | -13.7% | ||
| Q1 25 | 36.6% | 7.2% | ||
| Q4 24 | 32.8% | -56.2% | ||
| Q3 24 | 32.5% | -48.6% | ||
| Q2 24 | 36.5% | 5.1% | ||
| Q1 24 | 37.7% | 4.4% |
净利率PRXRAY
| Q4 25 | 29.0% | -15.2% | ||
| Q3 25 | 4.5% | -47.2% | ||
| Q2 25 | 17.3% | -4.8% | ||
| Q1 25 | 23.9% | 2.3% | ||
| Q4 24 | 16.7% | -47.5% | ||
| Q3 24 | 31.8% | -51.9% | ||
| Q2 24 | 18.9% | -0.4% | ||
| Q1 24 | 11.8% | 1.9% |
每股收益（稀释后）PRXRAY
| Q4 25 | $0.48 | $-0.74 | ||
| Q3 25 | $0.08 | $-2.14 | ||
| Q2 25 | $0.28 | $-0.22 | ||
| Q1 25 | $0.44 | $0.10 | ||
| Q4 24 | $0.31 | $-2.09 | ||
| Q3 24 | $0.53 | $-2.46 | ||
| Q2 24 | $0.36 | $-0.02 | ||
| Q1 24 | $0.25 | $0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $153.7M | $326.0M |
| 总债务越低越好 | $3.5B | $2.3B |
| 股东权益账面价值 | $10.3B | $1.3B |
| 总资产 | $17.9B | $5.4B |
| 负债/权益比越低杠杆越低 | 0.34× | 1.70× |
8季度趋势，按日历期对齐
现金及短期投资PRXRAY
| Q4 25 | $153.7M | $326.0M | ||
| Q3 25 | $111.8M | $363.0M | ||
| Q2 25 | $451.0M | $359.0M | ||
| Q1 25 | $702.2M | $398.0M | ||
| Q4 24 | $479.3M | $272.0M | ||
| Q3 24 | $272.0M | $296.0M | ||
| Q2 24 | $47.8M | $279.0M | ||
| Q1 24 | $12.7M | $291.0M |
总债务PRXRAY
| Q4 25 | $3.5B | $2.3B | ||
| Q3 25 | $3.5B | — | ||
| Q2 25 | $4.0B | — | ||
| Q1 25 | $4.0B | — | ||
| Q4 24 | $4.2B | $1.7B | ||
| Q3 24 | $4.2B | — | ||
| Q2 24 | $3.9B | — | ||
| Q1 24 | $3.9B | — |
股东权益PRXRAY
| Q4 25 | $10.3B | $1.3B | ||
| Q3 25 | $10.0B | $1.5B | ||
| Q2 25 | $9.5B | $2.0B | ||
| Q1 25 | $9.4B | $2.0B | ||
| Q4 24 | $9.1B | $1.9B | ||
| Q3 24 | $9.0B | $2.5B | ||
| Q2 24 | $8.3B | $3.1B | ||
| Q1 24 | $7.0B | $3.3B |
总资产PRXRAY
| Q4 25 | $17.9B | $5.4B | ||
| Q3 25 | $17.3B | $5.7B | ||
| Q2 25 | $17.5B | $6.1B | ||
| Q1 25 | $17.1B | $6.0B | ||
| Q4 24 | $16.9B | $5.8B | ||
| Q3 24 | $16.6B | $6.6B | ||
| Q2 24 | $15.4B | $6.9B | ||
| Q1 24 | $15.1B | $7.1B |
负债/权益比PRXRAY
| Q4 25 | 0.34× | 1.70× | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.42× | — | ||
| Q1 25 | 0.43× | — | ||
| Q4 24 | 0.46× | 0.90× | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.56× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $904.3M | $101.0M |
| 自由现金流经营现金流 - 资本支出 | — | $60.0M |
| 自由现金流率自由现金流/营收 | — | 6.2% |
| 资本支出强度资本支出/营收 | — | 4.3% |
| 现金转化率经营现金流/净利润 | 2.66× | — |
| 过去12个月自由现金流最近4个季度 | — | $104.0M |
8季度趋势，按日历期对齐
经营现金流PRXRAY
| Q4 25 | $904.3M | $101.0M | ||
| Q3 25 | $766.5M | $79.0M | ||
| Q2 25 | $1.0B | $48.0M | ||
| Q1 25 | $898.0M | $7.0M | ||
| Q4 24 | $871.6M | $87.0M | ||
| Q3 24 | $954.4M | $141.0M | ||
| Q2 24 | $938.4M | $208.0M | ||
| Q1 24 | $647.6M | $25.0M |
自由现金流PRXRAY
| Q4 25 | — | $60.0M | ||
| Q3 25 | — | $40.0M | ||
| Q2 25 | — | $16.0M | ||
| Q1 25 | — | $-12.0M | ||
| Q4 24 | — | $36.0M | ||
| Q3 24 | — | $98.0M | ||
| Q2 24 | — | $156.0M | ||
| Q1 24 | — | $-9.0M |
自由现金流率PRXRAY
| Q4 25 | — | 6.2% | ||
| Q3 25 | — | 4.4% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | -1.4% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 10.3% | ||
| Q2 24 | — | 15.9% | ||
| Q1 24 | — | -0.9% |
资本支出强度PRXRAY
| Q4 25 | — | 4.3% | ||
| Q3 25 | — | 4.3% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 5.6% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 5.3% | ||
| Q1 24 | — | 3.6% |
现金转化率PRXRAY
| Q4 25 | 2.66× | — | ||
| Q3 25 | 12.94× | — | ||
| Q2 25 | 5.01× | — | ||
| Q1 25 | 2.73× | 0.35× | ||
| Q4 24 | 4.02× | — | ||
| Q3 24 | 2.47× | — | ||
| Q2 24 | 3.99× | — | ||
| Q1 24 | 4.42× | 1.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PR
| Crude Oil | $1.0B | 87% |
| Natural Gas Liquids Reserves | $145.1M | 12% |
XRAY
| Essential Dental Solutions | $372.0M | 39% |
| Equipment And Instruments | $160.0M | 17% |
| Implants And Prosthetics | $150.0M | 16% |
| CADCAM | $139.0M | 14% |
| Wellspect Healthcare | $88.0M | 9% |
| Orthodontics | $52.0M | 5% |
